Calendar Daxor Corporation Nyse

Equities

DXR

US2394671034

Market Closed - Nyse 02:00:00 27/04/2024 am IST 5-day change 1st Jan Change
9.65 USD 0.00% Intraday chart for Daxor Corporation -0.92% +0.52%

Chart calendar Daxor Corporation

c.YNSRohHt26GdDWrOSaMeMO_WqioQ8oFkkMF0I7ksdxA.Layh0iHeqsrQWju_Jc1QfJjl-lJHrcM83oweS4FULXMCrfj1IoXtjOdvDQ~2a23a9c6b7092203d242f6da14591761

Upcoming events on Daxor Corporation

22/08/2024 Q2 2024 Earnings Release (Projected)
27/02/2025 Q4 2024 Earnings Release (Projected)
21/08/2025 Q2 2025 Earnings Release (Projected)
26/02/2026 Q4 2025 Earnings Release (Projected)

Past events on Daxor Corporation

18/04/2024 MedAxiom CV Transforum Spring Conference
06/04/2024 American College of Cardiology Scientific Meeting
26/03/2024 01:30 am Q4 2023 Earnings Call
18/03/2024 11:48 pm Q4 2023 Earnings Release
04/03/2024 Technology and Heart Failure Therapeutics Conference
01/02/2024 Society of Nuclear Medicine and Molecular Imaging Mid Winter and American College Nuclear Medicine M
21/01/2024 Society for Critical Care Medicine Congress
08/10/2023 Heart Failure Society of America Meeting
08/10/2023 Heart Failure Society Scientific Conference
06/10/2023 Heart Failure Society Scientific Meeting - Poster #339
05/10/2023 MedAxiom CV Transforum Fall Conference
11/09/2023 04:30 pm H.C. Wainwright Global Investment Conference
29/06/2023 American Association of Heart Failure Nurses Meeting
22/06/2023 01:00 am Maxim Group Virtual Healthcare Conference
20/04/2023 MedAxiom CV Transforum Spring Conference
19/04/2023 International Society for Heart and Lung Transplant Meeting - Poster #117.532
19/04/2023 International Society for Heart and Lung Transplant Meeting - Poster #116.531
19/04/2023 International Society for Heart and Lung Transplant Meeting - Poster #118.537
20/03/2023 Technology Heart Failure Therapeutics Conference
02/03/2023 07:30 pm Q4 2022 Earnings Call

Past dividends on Daxor Corporation

05/01/2018 Annual 0.03 USD
20/12/2016 Annual 0.03 USD
18/12/2015 0.04 USD
04/12/2014 0.03 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021
Net sales
Million USD
Released
Forecast
Spread
0,38
0,39
-3.5%
0,26
3,50
-92.44%
0,28
0,13
120.71%
EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,60
-
0,00
0,00
-
EBIT
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-0,50
0,21
-332.47%
0,00
0,00
-
4,75
-1,55
406.93%
Net income
Million USD
Released
Forecast
Spread
-0,50
0,32
-254.89%
0,00
0,00
-
4,75
-1,55
406.53%
EPS
USD
Released
Forecast
Spread
-0,13
0,08
-265.38%
-0,42
0,15
-381.33%
0,00
0,00
-
Announcement Date28/02/2025/02/2128/02/22

Quarterly results

Fiscal PeriodDecember 2021 S1
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-1,55


Net income
Million USD
Released
Forecast
Spread
-1,55


Announcement Date30/08/21

Net sales - Annual - Rate of surprise